The table below shows MARAVAI LIFESCIENCES HOLDINGS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$185.74M
$259.19M
$288.94M
$883.00M
$799.24M
$284.10M
Cost of revenue
$151.75M
$150.88M
$148.74M
$168.96M
$140.56M
$79.65M
Gross profit
$33.99M
$108.31M
$140.20M
-
-
-
R&D
$17.40M
$19.22M
$17.28M
$18.37M
$15.22M
$9.30M
MRVI annual revenue (10-K history)
MARAVAI LIFESCIENCES HOLDINGS, INC. reported annual revenue of $185.74M for fiscal year 2025. That is down 28.3% from $259.19M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $143.14M (FY 2019) to $185.74M. Figures come from the company's audited annual reports as filed with the SEC.